NCI's genomic characterization center - IDIQ contract period of performance 08/31/2019 - 08/30/2024
Ended Awarded Last action
- Contract number
- 75N91019D00030
- Awardee
-
Azenta US Inc. UEI FW1MQC5H7K56 Part of Azenta, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $2,203,820 obligated
Award facts
- Opportunity
-
- Solicitation for NCI Genomic Characterization Centers Pre-Solicitation · N02CO8700194 · Posted Nov 5, 2018
- Combined order value
-
- $2,203,820 Current, with exercised options
- $2,318,620 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 4% used
- $49,832,452.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The National Cancer Institute (NCI), part of the National Institutes of Health within the Department of Health and Human Services, has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Azenta US Inc., doing business as Brooks Life Sciences Inc., for the provision of genomic characterization services to support the NCI's Center for Cancer Genomics research programs. The IDIQ contract has a $49,832,452 ceiling value and a period of performance from August 31, 2019 through August 30, 2024.
Under this IDIQ contract, Azenta has received multiple firm-fixed price delivery orders to provide services such as DNA whole exome sequencing and other genomic characterization to aid in cancer research studies. The contract does not utilize small business set-asides. The work is primarily performed at Azenta's facility in South Plainfield, New Jersey. The original solicitation sought proposals from qualified contractors capable of operating high-throughput, validated genomic characterization pipelines to support the NCI's goal of integrating genomic data into cancer research and clinical care.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Novation Agreement | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N91019D00030?
75N91019D00030 was awarded to Azenta US Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2019.
How much is contract 75N91019D00030 worth?
Orders under 75N91019D00030 have obligated $2,203,820. Their combined potential value, with all options, is $2,318,620. 75N91019D00030's own ceiling is $49,832,452.
How many orders have been placed under contract 75N91019D00030?
3 orders have been placed under 75N91019D00030, the latest on August 30, 2024.
Who can order from contract 75N91019D00030?
75N91019D00030 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N91019D00030 part of a contract vehicle?
Yes. 75N91019D00030 is part of NCI Genomic Characterization Centers.
Was contract 75N91019D00030 competed?
The extent of competition for 75N91019D00030 was full and open competition. The government received 8 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV